Clinical Trial Update: ATX-GD-59 in Patients With Graves Disease Not Treated With Anti-thyroid Therapy [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for ATX-GD-59 in Graves disease patients not treated with anti-thyroid therapy has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graves Disease

Drugs mentioned

• ATX-GD-59

Snippet

Sponsor: Apitope International NV | Conditions: Graves Disease | Phase 1 | Status: COMPLETED | Results posted: 2019-06-14